Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients

被引：20
作者：
Takimoto, Takayuki [1 ]
Nakabori, Tasuku [1 ]
Osa, Akio [1 ]
Morita, Satomu [1 ]
Terada, Haruko [1 ]
Oseto, Susumu [1 ]
Iwazawa, Takashi [2 ]
Abe, Kinya [1 ]
机构：
[1] Toyonaka City Hosp, Dept Internal Med, Toyonaka, Osaka 5608565, Japan
[2] Toyonaka City Hosp, Dept Surg, Toyonaka, Osaka 5608565, Japan
来源：
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 17卷 / 04期
关键词：
Non-small-cell lung cancer (NSCLC); Chronic renal failure; Docetaxel; Tubular nephrotoxicity; beta(2)-Microglobulin; RENAL-FUNCTION; CISPLATIN; CHEMOTHERAPY; PLATINUM; TAXOTERE;
D O I：
10.1007/s10147-011-0304-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Renal dysfunction is a characteristic of many patients with cancer; however, a standard therapy has not been established for stage III or IV non-small-cell lung cancer (NSCLC) complicated with chronic renal failure. Docetaxel has a proven significant activity against NSCLC. This agent is predominantly eliminated by hepatobiliary extraction and is safe in patients with renal failure, including dialysis patients. Docetaxel is, thus, a therapeutic option in that patient population. Here, we report acute tubular nephrotoxicity secondary to docetaxel in NSCLC patients, even in patients with normal renal function. Little is known about tubular nephrotoxicity induced by docetaxel; however, oncologists should be aware of its possibility.
引用
收藏
页码：395 / 398
页数：4
相关论文
共 50 条
  • [31] A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer
    Athanasios Kotsakis
    Sophia Agelaki
    Nikolaos Vardakis
    George Stathopoulos
    Lambros Vamvakas
    Antonia Kalykaki
    Nikolaos Kentepozidis
    Emmanouel Kontopodis
    Georgia Sfakiotaki
    Dimitris Mavroudis
    Vassilis Georgoulias
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 68 : 415 - 422
  • [32] Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy
    Wen, Shimin
    Fu, Xi
    Li, Guangming
    He, Lang
    Zhao, Caixia
    Hu, Xin
    Pan, Rongqiang
    Guo, Cuihua
    Zhang, Xinping
    Hu, Xingsheng
    [J]. ANTI-CANCER DRUGS, 2016, 27 (05) : 447 - 456
  • [33] Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
    Chen, YM
    Perng, RP
    Lin, WC
    Wu, HW
    Tsai, CM
    Whang-Peng, J
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 509 - 512
  • [34] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Masahiro Tabata
    Toshiyuki Kozuki
    Hiroshi Ueoka
    Katsuyuki Kiura
    Shingo Harita
    Atsuhiko Tada
    Takuo Shibayama
    Nagio Takigawa
    Toshiro Yonei
    Kenichi Gemba
    Yoshihiko Segawa
    Daizo Kishino
    Shinya Tada
    Shunkichi Hiraki
    Mitsune Tanimoto
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 53 - 59
  • [35] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Tabata, Masahiro
    Kozuki, Toshiyuki
    Ueoka, Hiroshi
    Kiura, Katsuyuki
    Harita, Shingo
    Tada, Atsuhiko
    Shibayama, Takuo
    Takigawa, Nagio
    Yonei, Toshiro
    Gemba, Kenichi
    Segawa, Yoshihiko
    Kishino, Daizo
    Tada, Shinya
    Hiraki, Shunkichi
    Tanimoto, Mitsune
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 53 - 59
  • [36] The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis
    Wailoo, A.
    Sutton, A.
    Morgan, A.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 436 - 441
  • [37] Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non-Small-Cell Lung Cancer
    Liao, Wei-Yu
    Chen, Jin-Hsin
    Wu, Muzo
    Shih, Jin-Yuan
    Chen, Kuan-Yuh
    Ho, Chao-Chi
    Yang, James Chih-Hsin
    Yu, Chong-Jen
    [J]. CLINICAL LUNG CANCER, 2013, 14 (04) : 418 - 424
  • [38] Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer
    Kaira, K
    Takise, A
    Minato, K
    Iwasaki, Y
    Ishihara, S
    Takei, Y
    Tsuchiya, S
    Saito, R
    Sato, K
    Mori, M
    [J]. ANTI-CANCER DRUGS, 2005, 16 (04) : 455 - 460
  • [39] Maintenance chemotherapy for non-small-cell lung cancer
    Kim, Young Hak
    Mishima, Michiaki
    [J]. CANCER TREATMENT REVIEWS, 2011, 37 (07) : 505 - 510
  • [40] A REVELation in non-small-cell lung cancer treatment?
    Mok, Tony S. K.
    Loong, Herbert H.
    [J]. LANCET, 2014, 384 (9944) : 640 - 642
12345